Testing effectiveness (Phase 2)Active Not RecruitingNCT06712836
What this trial is testing
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight
Who this might be right for
ObesityOverweight or Obesity
Metsera, a wholly owned subsidiary of Pfizer 225